The Cigna Group
CI
$309.83
$2.480.81%
Weiss Ratings | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | B- | |||
Rating Factors | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Fair | |||
Growth Index | Good | |||
Efficiency Index | Good | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.63 | |||
Price History | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 3.43% | |||
30-Day Total Return | 7.89% | |||
60-Day Total Return | -5.68% | |||
90-Day Total Return | -1.99% | |||
Year to Date Total Return | 13.43% | |||
1-Year Total Return | -5.74% | |||
2-Year Total Return | 11.16% | |||
3-Year Total Return | 37.05% | |||
5-Year Total Return | 65.18% | |||
52-Week High % Change | -16.71% | |||
52-Week Low % Change | 17.87% | |||
Price | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $370.83 | |||
52-Week Low Price | $262.03 | |||
52-Week Low Price (Date) | Dec 17, 2024 | |||
52-Week High Price (Date) | Sep 16, 2024 | |||
Valuation | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 84.53B | |||
Enterprise Value | 108.50B | |||
Price/Earnings (TTM) | 25.25 | |||
Earnings Per Share (TTM) | 12.23 | |||
Earnings Per Share Growth | -29.66% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.35 | |||
Price/Book (Q) | 2.06 | |||
Enterprise Value/Revenue (TTM) | 0.44 | |||
Price | $309.83 | |||
Enterprise Value/EBITDA (TTM) | 8.70 | |||
Enterprise Value/EBIT | 11.19 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 277.78M | |||
Dividend Yield | 1.81% | |||
Div. Per Share (Most Recent) | $1.40 | |||
Dividend Per Share (TTM) | $5.60 | |||
Payout Ratio (TTM) | 45.63% | |||
Dividend Per Share (Most Recent) | $1.40 | |||
Company Info | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 860 226 6000 | |||
Address | 900 Cottage Grove Road Bloomfield, CT 06002 | |||
Website | www.cigna.com | |||
Country | United States | |||
Year Founded | 1792 | |||
Profitability | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 3.92% | |||
Profit Margin | 1.38% | |||
Management Effectiveness | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 3.93% | |||
Return on Equity | 8.63% | |||
Income Statement | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 246.15B | |||
Total Revenue (TTM) | 247.12B | |||
Revenue Per Share | $889.62 | |||
Gross Profit (TTM) | 25.96B | |||
EBITDA (TTM) | 12.47B | |||
EBIT (TTM) | 9.69B | |||
Net Income (TTM) | 3.43B | |||
Net Income Avl. to Common (TTM) | 3.43B | |||
Total Revenue Growth (Q YOY) | 28.44% | |||
Earnings Growth (Q YOY) | 38.75% | |||
EPS Diluted (TTM) | 12.23 | |||
EPS Diluted Growth (Q YOY) | 46.76% | |||
Balance Sheet | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 8.22B | |||
Cash Per Share (Q) | $29.57 | |||
Total Current Assets (Q) | 48.87B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 41.24B | |||
Current Ratio (Q) | 0.843 | |||
Book Value Per Share (Q) | $149.87 | |||
Total Assets (Q) | 155.88B | |||
Total Current Liabilities (Q) | 57.98B | |||
Total Debt (Q) | 31.97B | |||
Total Liabilities (Q) | 114.64B | |||
Total Common Equity (Q) | 41.03B | |||
Cash Flow | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -2.10B | |||
Cash from Financing (TTM) | -7.65B | |||
Net Change in Cash (TTM) | -745.00M | |||
Levered Free Cash Flow (TTM) | 3.92B | |||
Cash from Operations (TTM) | 10.36B | |||